Scheduling status for Naproxen sodium 220 mg

June 16, 2009

The initial recommendations made by the National Drug Scheduling Advisory Committee (NDSAC) for the scheduling of Naproxen were finalized effective June 11, 2009 to read as follows:

  • Naproxen sodium 220 mg tablet (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes of up to 6,600 mg) - Schedule III
  • Naproxen sodium 220 mg tablet (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6,600 mg) - Schedule II

The National Drug Schedules will be revised accordingly.

Originally published in the June 16, 2009, issue of The Link


← Previous ArticleNext Article →